StarWorld Macau played unlucky in its gaming operations which decreased its Adjusted EBITDA by approximately $4 million in Q3 2025. Normalized Adjusted EBITDA was $373 million, down 2% year-on-year ...
ALBUQUERQUE, N.M., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Crogl, the cybersecurity risk management company, today announced that it has received a patent (US12277177B1) that enables its knowledge engine to ...
StockStory.org on MSN
LSCC Q3 Deep Dive: Data Center and AI Demand Drive Guidance, Inventory Normalization in Focus
Semiconductor designer Lattice Semiconductor (NASDAQ:LSCC) in Q3 CY2025, with sales up 4.9% year on year to $133.3 million.
- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
Penumbra reported positive data for a trial of its treatment for pulmonary embolism. The use of computer-assisted vacuum thrombectomy resulted in improvements in thrombus burden reduction, heart rate, ...
Privacy advocates urge the FTC to block Meta’s plan to use chatbot conversations for "tailoring" content and ads served ...
Straight Arrow News on MSNOpinion
Normalizing Nazis: How extremism moved from fringe to mainstream
Nazi imagery and symbolism are increasingly moving from the darkest corners of American society to its political mainstream, ...
The Yen immediately weakened, USD/JPY quickly climbed from below, while the Japanese stock market (Nikkei) rose, and Japanese ...
Learn how healthcare data aggregation breaks silos and enables value-based care through AI, lakehouse architecture, and ...
Challenges with data quality and data governance have plagued healthcare analytics efforts for decades – and the stakes are only getting higher in the age of AI. Inaccurate or inconsistent data ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Building a data-driven culture is a business transformation. Too often, organizations treat ...
MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a clinical-stage pharmaceutical company developing novel oral therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results